| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |